MLN FY24 NPAT up 57.6% to NZ$37.2m on a second-half-heavy portfolio result

What changed

FY24 revenue rose 55.4% to NZ$42.9m from NZ$27.6m, and net profit after tax rose 57.6% to NZ$37.2m from NZ$23.6m. All of the reported profit came from continuing operations, with no discontinued operation disclosed in either period. A final dividend of NZ2.07 cents per share was declared; no prior-period comparison for the final dividend is supplied, so the year-on-year payout trajectory cannot be stated from this release. Balance-sheet, operating cash flow, capex and net-debt figures were not captured in usable form in the extraction (total assets show as a nominal NZ$0.03m, which is clearly an OCR artefact rather than a real figure).

What matters

• Result shape is heavily back-ended. HY24 delivered only NZ$12.4m of revenue (28.8% of FY24) and NZ$10.2m of NPAT (27.4% of FY24), implying an H2 of roughly NZ$30.6m revenue and NZ$27.0m NPAT. For an investment vehicle, that pattern is a statement about mark-to-market movements in the second half rather than a run-rate.
• NPAT read is clean at the headline but opaque underneath. PBT and tax expense are not disclosed in the full-year extraction, so the tax bridge cannot be checked; NPAT is the only usable earnings measure here. The prior-period tax treatment also cannot be compared.
• Dividend is declared without a clear coverage test. With no operating cash flow, no free cash flow and no realised-versus-unrealised split disclosed, the NZ2.07 cps final dividend cannot be tested against cash generation in this filing.

Expectations

No explicit FY24 target, forward-work book, or prior guidance is supplied, so the result cannot be measured against management expectations. Against the only shape reference available — HY24 — the second half was materially stronger on both revenue and NPAT. For a listed investment company that pattern typically reflects portfolio revaluation rather than recurring trading income, so the H2 acceleration should not be extrapolated as a forward run-rate without portfolio-level disclosure.

Quality of result

Earnings quality cannot be robustly assessed from the supplied data. The NPAT-to-revenue ratio of 86.6% (NZ$37.2m on NZ$42.9m) is consistent with an investment vehicle where "revenue" largely comprises dividend income and investment gains rather than traded revenue, and where much of the gain may be unrealised. HY24 operating cash flow was negative NZ$11.4m, which is normal for such a structure but means the interim profit was not cash-backed at the half; the FY24 operating cash flow is not disclosed in the extraction, so whether the full-year profit converted to cash is unknown. Working-capital and receivables ratios in the calculation pack are not meaningful for this business model.

Unresolved

• What is the split between realised gains, unrealised mark-to-market movements, and dividend income inside the NZ$42.9m revenue line?
• What was FY24 operating cash flow, and did the strong H2 NPAT convert to cash or was it predominantly unrealised?
• What is the PBT and effective tax rate for FY24, and is the tax charge consistent with the prior period's treatment?
• What are the correct FY24 total assets, cash, and net asset value per share (the extracted balance-sheet figures are not usable)?
• How does the NZ2.07 cps final dividend compare to FY23's full-period distribution, and what is the payout policy against NTA?

This briefing cannot assess portfolio composition, realised-versus-unrealised earnings mix, cash generation, or net asset backing because those disclosures were not present in the supplied extraction.

Key metrics

Analytical metrics

This analysis was generated using Annolyse, an AI-powered tool that analyses NZX company announcements. The analysis is based on available company filings and standard Annolyse calculations. This is general information only and does not constitute financial advice. The analysis may contain errors. Always read the original company filings and consult a licensed financial adviser before making investment decisions.